Clinical Trial Update: Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA) [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports on strategies for managing initial bleeding and spotting associated with the levonorgestrel-releasing intrauterine sy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Hemorrhage

Drugs mentioned

• Mirena (levonorgestrel-releasing intrauterine system)

Snippet

Sponsor: Bayer | Conditions: Uterine Hemorrhage | Phase 4 | Status: COMPLETED